Table 1 Baseline characteristics of the study subjects

From: Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure

 

Placebo group (n=227)

Telmisartan group (n=219)

Indapamide group (n=209)

P-value

Age (years)

64.9±7.2

65.4±6.9

65.3±7.0

0.800

Male sex, n (%)

71 (31.3)

72 (32.9)

65 (31.1)

0.909

WC (cm)

87.2±9.1

87.0±8.5

87.3±8.3

0.935

SBP (mm Hg)

134.5±3.0

134.7±2.6

134.7±2.8

0.613

DBP (mm Hg)

82.0±5.0

82.3±4.8

82.2±4.6

0.859

TG (mmol l−1)

1.5±0.4

1.5±0.5

1.5±0.5

0.605

HDL-C (mmol l−1)

1.5±0.4

1.5±0.5

1.5±0.4

0.666

LDL-C (mmol l−1)

3.1±0.9

3.1±0.9

3.2±0.9

0.620

FPG (mmol l−1)

5.3±0.7

5.4±0.7

5.3±0.6

0.902

  1. Abbreviations: DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; SBP, systolic blood pressure; TG, triglycerides; WC, waist circumference.
Back to article page